Generic Zoloft

While Pfizer, one of the largest pharmaceutical manufacturing sources in the world, challenges copycat makers of generic Zoloft (or any generic version of a brand pharmaceutical Pfizer manufactures under their own patent), the reality is that there are always scientists, inventors, and engineers working on reinventing the wheel…or on refining medications and treatments such as generic Zoloft—making such a recreation more affordable and more accessible. Pfizer owns the patent to Zoloft. In fact, Pfizer owns two patents relating to Zoloft, so when Teva, a generic drug manufacturer filed an ANDA (an Abbreviated New Drug Application) to get its newly developed generic Zoloft version of sertraline hydrochloride (Zoloft®) approved, Pfizer challenged with a dispute—instead of suing, which the company had a right to do, within 45 days of Teva’s ANDA filings.. Teva did [attempt to] sue, based on infringement of rights to create, develop, and manufacture a simulation that it claimed was not stepping on Zoloft’s toes, but the District Court

in Massachusetts tossed the suit and decided in favor of Pfizer. So generic Zoloft still has to contend with its founding father, Zoloft. The tests done as follow-up on patient satisfaction are as repeatedly positive as they are negative, and the courts are thus far, along with the FDA, finding Zoloft free of culpability in aggression, suicide, and homicide cases—where Zoloft users, not generic Zoloft users are found to have side effects that they maintain caused the crime. That is, while it sometimes helps immensely to purchase a cheaper version, a simulation, an imitation, it also still holds true that the real thing can many times produce better—or at least, different--results.